Literature DB >> 29873242

Stachydrine suppresses viability & migration of astrocytoma cells via CXCR4/ERK & CXCR4/Akt pathway activity.

Yun Liu1, Songzhi Wei2, Qin Zou1, Yan Luo3.   

Abstract

AIM: Pilocytic astrocytomas (PAs) are a common adolescent malignancy. We evaluated the effects of the betaine stachydrine on human PA cells as well as its associated molecular mechanism(s). MATERIALS &
METHODS: Various experiments assessing stachydrine's effects on the human PA cell line Res186 were performed. RESULTS &
CONCLUSION: Stachydrine dose-dependently suppressed proliferation and colony formation in Res186 cells with no such effect on normal astrocytes. Stachydrine downregulated CXCR4 transcription through enhancing IκBα-based NF-κB inhibition. Stachydrine promoted apoptosis and cyclin D1/p27Kip1-associated G0/G1 phase arrest in a CXCR4/ERK- and CXCR4/Akt-dependent manner. Stachydrine suppressed MMP-associated migration and invasiveness via inhibiting CXCR4/Akt/MMP-9/2 and CXCR4/ERK/MMP-9/2 pathway activity. Stachydrine inhibits the viability, migration and invasiveness of human PA cells via inhibiting CXCR4/ERK and CXCR4/Akt signaling.

Entities:  

Keywords:  PA; cancer; glioma; pilocytic astrocytoma; stachydrine

Mesh:

Substances:

Year:  2018        PMID: 29873242     DOI: 10.2217/fon-2017-0562

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  5 in total

Review 1.  Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment.

Authors:  Yanming Luo; Shuangshuang Yin; Jia Lu; Shiyue Zhou; Yingying Shao; Xiaomei Bao; Tao Wang; Yuling Qiu; Haiyang Yu
Journal:  Cancer Cell Int       Date:  2021-07-20       Impact factor: 5.722

2.  Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling.

Authors:  Jiahong Meng; Chenhe Zhou; Wenkan Zhang; Wei Wang; Bin He; Bin Hu; Guangyao Jiang; Yangxin Wang; Jianqiao Hong; Sihao Li; Jiamin He; Shigui Yan; Weiqi Yan
Journal:  J Cell Mol Med       Date:  2019-07-21       Impact factor: 5.310

3.  Interaction network of immune-associated genes affecting the prognosis of patients with glioblastoma.

Authors:  Xiaohong Hou; Jialin Chen; Qiang Zhang; Yinchun Fan; Chengming Xiang; Guiyin Zhou; Fang Cao; Shengtao Yao
Journal:  Exp Ther Med       Date:  2020-11-19       Impact factor: 2.447

4.  Stachydrine is effective and selective against blast phase chronic myeloid leukaemia through inhibition of multiple receptor tyrosine kinases.

Authors:  Ruixin Gu; Wei Zhang; Dandan Xu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

5.  A mitochondria-targeted nano-platform for pancreatic cancer therapy.

Authors:  Xiaoke Tan; Xin Zhu; Duanjie Xu; Yanmei Shi; Zhenzhen Wang; Mingzhuo Cao; Kai Hu; Lingzhou Zhao; Junwei Zhao; Mingsan Miao; Huahui Zeng; Xiangxiang Wu
Journal:  Front Chem       Date:  2022-09-21       Impact factor: 5.545

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.